Literature DB >> 19171732

Exenatide-associated ischemic renal failure.

Wolfgang J Weise, Mala S Sivanandy, Clay A Block, Richard J Comi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19171732     DOI： 10.2337/dc08-1309

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  28 in total

Review 1.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 2.  Adverse Effects of GLP-1 Receptor Agonists.

Authors:  Theodosios D Filippatos; Thalia V Panagiotopoulou; Moses S Elisaf
Journal:  Rev Diabet Stud       Date:  2015-02-10

3.  Novel treatments for type 2 diabetes.

Authors:  Jason Seewoodhary; Stephen C Bain
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

4.  A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus.

Authors:  Huibiao Quan; Huachuan Zhang; Weiping Wei; Tuanyu Fang; Daoxiong Chen; Kaining Chen
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

Review 5.  Extra-pancreatic effects of incretin-based therapies.

Authors:  Baptist Gallwitz
Journal:  Endocrine       Date:  2014-03-07       Impact factor: 3.633

6.  Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers.

Authors:  Alfonso López-Ruiz; Cristina del Peso-Gilsanz; Amparo Meoro-Avilés; José Soriano-Palao; Alberto Andreu; Juan Cabezuelo; José L Arias
Journal:  Pharm World Sci       Date:  2010-08-05

Review 7.  Advances in pharmacologic therapies for type 2 diabetes.

Authors:  Linde M Morsink; Mark M Smits; Michaela Diamant
Journal:  Curr Atheroscler Rep       Date:  2013-02       Impact factor: 5.113

Review 8.  Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

Review 9.  Update on the treatment of type 2 diabetes mellitus.

Authors:  Juan José Marín-Peñalver; Iciar Martín-Timón; Cristina Sevillano-Collantes; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2016-09-15

Review 10.  Emerging treatments for post-transplantation diabetes mellitus.

Authors:  Trond Jenssen; Anders Hartmann
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.